• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因启动子低甲基化与膀胱癌恶性表型相关。

Hypomethylation of Gene Promoter Is Associated with Malignant Phenotype in Urinary Bladder Cancer.

机构信息

Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, Japan.

Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8522, Nara, Japan.

出版信息

Int J Mol Sci. 2022 Jun 10;23(12):6516. doi: 10.3390/ijms23126516.

DOI:10.3390/ijms23126516
PMID:35742959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9224287/
Abstract

The tight junction (TJ) protein claudin-4 (CLDN4) is overexpressed in bladder urothelial carcinoma (BUC) and correlates with cancer progression. However, the mechanism of CLDN4 upregulation and promotion of malignant phenotype is not clear. Here, we analyzed 157 cases of BUC and investigated the hypomethylation of CpG island in the promoter DNA and its correlation with cancer progression. In hypomethylated cases, CLDN4 expression, cell proliferation, stemness, and epithelial-mesenchymal transition were increased. Treatment of three human BUC cell lines with the demethylating agent aza-2'-deoxycytidine (AZA) led to excessive CLDN4 expression, and, specifically, to an increase in CLDN4 monomer that is not integrated into the TJ. The TJ-unintegrated CLDN4 was found to bind integrin β1 and increase stemness, drug resistance, and metastatic ability of the cells as well as show an anti-apoptosis effect likely via FAK phosphorylation, which reduces upon knockdown of CLDN4. Thus, CLDN4 is overexpressed in BUC by an epigenetic mechanism and the high expression enhances the malignant phenotype of BUC via increased levels of TJ-unintegrated CLDN4. promoter DNA methylation is expected to be a novel indicator of BUC malignant phenotype and a new therapeutic target.

摘要

紧密连接 (TJ) 蛋白 Claudin-4 (CLDN4) 在膀胱尿路上皮癌 (BUC) 中过度表达,并与癌症进展相关。然而,CLDN4 上调及其促进恶性表型的机制尚不清楚。在这里,我们分析了 157 例 BUC,并研究了启动子 DNA 中 CpG 岛的低甲基化及其与癌症进展的相关性。在低甲基化病例中,CLDN4 的表达、细胞增殖、干性和上皮-间充质转化增加。用去甲基化剂阿扎 -2'-脱氧胞苷 (AZA) 处理三种人 BUC 细胞系导致 CLDN4 过度表达,特别是 TJ 未整合的 CLDN4 单体增加。发现 TJ 未整合的 CLDN4 与整合素 β1 结合,增加细胞的干性、耐药性和转移能力,并具有抗细胞凋亡作用,可能通过 FAK 磷酸化,而 CLDN4 的敲低会降低 FAK 磷酸化。因此,CLDN4 通过表观遗传机制在 BUC 中过度表达,高表达通过增加 TJ 未整合的 CLDN4 水平增强 BUC 的恶性表型。启动子 DNA 甲基化有望成为 BUC 恶性表型的一个新指标和一个新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8a/9224287/42cd17c3b38b/ijms-23-06516-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8a/9224287/60e44c2a0ed4/ijms-23-06516-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8a/9224287/2058cfaacd26/ijms-23-06516-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8a/9224287/eabc5565b15c/ijms-23-06516-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8a/9224287/699599550b31/ijms-23-06516-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8a/9224287/a4c14bd63d8d/ijms-23-06516-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8a/9224287/42cd17c3b38b/ijms-23-06516-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8a/9224287/60e44c2a0ed4/ijms-23-06516-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8a/9224287/2058cfaacd26/ijms-23-06516-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8a/9224287/eabc5565b15c/ijms-23-06516-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8a/9224287/699599550b31/ijms-23-06516-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8a/9224287/a4c14bd63d8d/ijms-23-06516-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f8a/9224287/42cd17c3b38b/ijms-23-06516-g006.jpg

相似文献

1
Hypomethylation of Gene Promoter Is Associated with Malignant Phenotype in Urinary Bladder Cancer.基因启动子低甲基化与膀胱癌恶性表型相关。
Int J Mol Sci. 2022 Jun 10;23(12):6516. doi: 10.3390/ijms23126516.
2
Claudin-4: A New Molecular Target for Epithelial Cancer Therapy.Claudin-4:上皮癌治疗的新分子靶点。
Int J Mol Sci. 2023 Mar 13;24(6):5494. doi: 10.3390/ijms24065494.
3
Role of Nuclear Claudin-4 in Renal Cell Carcinoma.核 Claudin-4 在肾细胞癌中的作用。
Int J Mol Sci. 2020 Nov 6;21(21):8340. doi: 10.3390/ijms21218340.
4
Claudin-4 overexpression is associated with epigenetic derepression in gastric carcinoma.Claudin-4 过表达与胃癌中表观遗传去抑制有关。
Lab Invest. 2011 Nov;91(11):1652-67. doi: 10.1038/labinvest.2011.117. Epub 2011 Aug 15.
5
Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.Claudin-3 和 claudin-4 通过控制铜和顺铂内流转运蛋白 CTR1 的表达来调节对顺铂的敏感性。
Mol Pharmacol. 2013 Jan;83(1):85-94. doi: 10.1124/mol.112.079798. Epub 2012 Oct 10.
6
Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4.Claudin-3和Claudin-4对上皮-间质转化的调控
PLoS One. 2013 Jun 21;8(6):e67496. doi: 10.1371/journal.pone.0067496. Print 2013.
7
Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases.紧密连接蛋白 Claudin-3 和 Claudin-4 控制肿瘤生长和转移。
Neoplasia. 2012 Oct;14(10):974-85. doi: 10.1593/neo.12942.
8
DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma.人类膀胱癌中紧密连接蛋白4表达的DNA甲基化依赖性改变
Carcinogenesis. 2007 Feb;28(2):246-58. doi: 10.1093/carcin/bgl120. Epub 2006 Jul 8.
9
Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor β.Claudin-4 黏附信号通过肝 X 受体 β 驱动乳腺癌代谢和进展。
Breast Cancer Res. 2023 Apr 14;25(1):41. doi: 10.1186/s13058-023-01646-z.
10
DNA demethylation of claudin-4 suppresses migration and invasion in laryngeal squamous carcinoma cells.Claudin-4 的 DNA 去甲基化抑制喉鳞状细胞癌细胞的迁移和侵袭。
Hum Pathol. 2018 May;75:71-80. doi: 10.1016/j.humpath.2018.02.005. Epub 2018 Feb 13.

引用本文的文献

1
Intervention of machine learning in bladder cancer research using multi-omics datasets: systematic review on biomarker identification.利用多组学数据集的机器学习在膀胱癌研究中的干预:生物标志物识别的系统评价
Discov Oncol. 2025 Jun 5;16(1):1010. doi: 10.1007/s12672-025-02734-6.
2
Application of biomechanics in tumor epigenetic research.生物力学在肿瘤表观遗传学研究中的应用。
Mechanobiol Med. 2024 Aug 22;2(4):100093. doi: 10.1016/j.mbm.2024.100093. eCollection 2024 Dec.
3
Epigenetic modifications in bladder cancer: crosstalk between DNA methylation and miRNAs.

本文引用的文献

1
Inhibition of matrix stiffness relating integrin β1 signaling pathway inhibits tumor growth in vitro and in hepatocellular cancer xenografts.抑制基质硬度与整合素 β1 信号通路相关,可抑制肝癌细胞系异种移植瘤的生长。
BMC Cancer. 2021 Nov 25;21(1):1276. doi: 10.1186/s12885-021-08982-3.
2
The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update.烟酰胺 N-甲基转移酶作为一种潜在的生物标志物预测泌尿系统癌症的肿瘤学预后的效用:更新。
Biomolecules. 2021 Aug 16;11(8):1214. doi: 10.3390/biom11081214.
3
Differential glycosylation of collagen modulates lung cancer stem cell subsets through β1 integrin-mediated interactions.
膀胱癌中的表观遗传修饰:DNA甲基化与微小RNA之间的相互作用
Front Immunol. 2025 Feb 5;16:1518144. doi: 10.3389/fimmu.2025.1518144. eCollection 2025.
4
Claudins in Cancer: A Current and Future Therapeutic Target.紧密连接蛋白在癌症中的作用:当前和未来的治疗靶点。
Int J Mol Sci. 2024 Apr 24;25(9):4634. doi: 10.3390/ijms25094634.
5
Immunohistochemical Expression of Claudin-1 and Claudin-4 in Urothelial Carcinoma of the Urinary Bladder.Claudin-1 和 Claudin-4 在膀胱尿路上皮癌中的免疫组化表达。
Asian Pac J Cancer Prev. 2024 Feb 1;25(2):637-646. doi: 10.31557/APJCP.2024.25.2.637.
6
ERVK13-1/miR-873-5p/GNMT Axis Promotes Metastatic Potential in Human Bladder Cancer though Sarcosine Production.ERVK13-1/miR-873-5p/GNMT 轴通过肌氨酸生成促进人膀胱癌的转移潜能。
Int J Mol Sci. 2023 Nov 15;24(22):16367. doi: 10.3390/ijms242216367.
7
Claudin-4: A New Molecular Target for Epithelial Cancer Therapy.Claudin-4:上皮癌治疗的新分子靶点。
Int J Mol Sci. 2023 Mar 13;24(6):5494. doi: 10.3390/ijms24065494.
胶原的差异糖基化通过β1 整合素介导的相互作用调节肺癌干细胞亚群。
Cancer Sci. 2021 Jan;112(1):217-230. doi: 10.1111/cas.14700. Epub 2020 Nov 10.
4
Role of Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/ Polyps with Dysplasia.肠毒素在伴异型增生的结直肠无蒂锯齿状腺瘤/息肉中对 YAP 激活的作用。
Int J Mol Sci. 2020 May 28;21(11):3840. doi: 10.3390/ijms21113840.
5
Bladder Cancer Chemosensitivity is Affected by Paraoxonase-2 Expression.对氧磷酶-2的表达影响膀胱癌的化学敏感性。
Antioxidants (Basel). 2020 Feb 20;9(2):175. doi: 10.3390/antiox9020175.
6
Clostridium perfringens enterotoxin induces claudin-4 to activate YAP in oral squamous cell carcinomas.产气荚膜梭菌肠毒素诱导claudin-4激活口腔鳞状细胞癌中的YAP。
Oncotarget. 2020 Jan 28;11(4):309-321. doi: 10.18632/oncotarget.27424.
7
Targeting claudin-4 enhances chemosensitivity of pancreatic ductal carcinomas.靶向紧密连接蛋白 4 增强胰腺导管腺癌的化疗敏感性。
Cancer Med. 2019 Nov;8(15):6700-6708. doi: 10.1002/cam4.2547. Epub 2019 Sep 9.
8
Role of integrin β1 as a biomarker of stemness in head and neck squamous cell carcinoma.整合素β1 在头颈部鳞状细胞癌中的干细胞标志物作用。
Oral Oncol. 2019 Sep;96:34-41. doi: 10.1016/j.oraloncology.2019.07.001. Epub 2019 Jul 4.
9
Advances in epigenetics link genetics to the environment and disease.表观遗传学的进展将遗传学与环境和疾病联系起来。
Nature. 2019 Jul;571(7766):489-499. doi: 10.1038/s41586-019-1411-0. Epub 2019 Jul 24.
10
Targeting claudin-4 enhances CDDP-chemosensitivity in gastric cancer.靶向claudin-4可增强胃癌对顺铂的化疗敏感性。
Oncotarget. 2019 Mar 15;10(22):2189-2202. doi: 10.18632/oncotarget.26758.